Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus

J Diabetes Res. 2017:2017:2823671. doi: 10.1155/2017/2823671. Epub 2017 Sep 14.

Abstract

Brain-derived neurotrophic factor (BDNF) is a neurotrophin, which plays an important role in the central nervous system, and systemic or peripheral inflammatory conditions, such as acute coronary syndrome and type 2 diabetes mellitus (T2DM). BDNF is also expressed in several nonneuronal tissues, and platelets are the major source of peripheral BDNF. Here, we reviewed the potential role of BDNF in platelet reactivity in T2DM and its association with selected inflammatory and platelet activation mediators. Besides that, we focused on adipocytokines such as leptin, resistin, and adiponectin which are considered to take part in inflammation and both lipid and glucose metabolism in diabetic patients as previous studies showed the relation between adipocytokines and BDNF. We also reviewed the evidences of the antidiabetic effect of BDNF and the association with circulating inflammatory cytokines in T2DM.

Publication types

  • Review

MeSH terms

  • Adipokines / blood
  • Animals
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / physiopathology
  • Brain-Derived Neurotrophic Factor / adverse effects
  • Brain-Derived Neurotrophic Factor / blood
  • Brain-Derived Neurotrophic Factor / therapeutic use*
  • Cytokines / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / physiopathology
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Inflammation / blood*
  • Inflammation / epidemiology
  • Inflammation / physiopathology
  • Inflammation Mediators / blood
  • Platelet Activation / drug effects
  • Receptor, trkB / agonists
  • Receptor, trkB / metabolism
  • Signal Transduction / drug effects
  • Treatment Outcome

Substances

  • Adipokines
  • Blood Glucose
  • Brain-Derived Neurotrophic Factor
  • Cytokines
  • Hypoglycemic Agents
  • Inflammation Mediators
  • BDNF protein, human
  • Receptor, trkB